The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Statins: mechanism of action and effects
Open accessAbstract
The beneficial effects of statins are the result of their capacity to reduce cholesterol biosyntesis, mainly in the liver, where they are selectively distributed, as well as to the modulation of lipid metabolism, derived from their effect of inhibition upon HMG‐CoA reductase. Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert antiatherosclerotic effects independently of their hypolipidemic action. Because the mevalonate metabolism generates a series of isoprenoids vital for different cellular functions, from cholesterol synthesis to the control of cell growth and differentiation, HMG‐CoA reductase inhibition has beneficial pleiotropic effects. Consequently, statins reduce significantly the incidence of coronary events, both in primary and secondary prevention, being the most efficient hypolipidemic compounds that have reduced the rate of mortality in coronary patients. Independent of their hypolipidemic properties, statins interfere with events involved in bone formation and impede tumor cell growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the Statin class of drugs inhibit 3-hydroxy-3-methylglutaryl (HMG) CoA reductase (HMGCR), the rate-limiting enzyme of de novo cholesterol synthesis5”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Statins (3-Hydroxy-3-methylglutaryl CoA reductase inhibitors) inhibit the endogenous synthesis of cholesterol by inhibiting the rate-limiting enzyme of the mevalonate pathway.(14)”
From Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis (2025) · cites this paper as [14]
In the citing paper
“Statins are competitive inhibitors of HMG-CoA reductase, which catalyses the conversion of HMG-CoA to mevalonate, a rate-limiting step in the isoprenoid biosynthetic pathway, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi [10] .”
From Statins as antifungal agents (2011) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Current Perspectives on Statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,216
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P. L., Moskowitz, M. A., & Liao, J. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8880 · Cited by 957
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
The evolving role of statins in the management of atherosclerosis
Vaughan, C. J., Gotto, A. M., & Basson, C. T. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00525-2 · Cited by 573
Lennernäs, H., & Fager, G. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732050-00005 · Cited by 527
Wagner, A. H., Köhler, T. C., Rueckschloss, U., Just, I., & Hecker, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.61 · Cited by 517
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages
Bellosta, S., Via, D. P., Canavesi, M., Pfister, P., Fumagalli, R., Paoletti, R., & Bernini, F. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1671 · Cited by 512
Research works printed but not linked: 2
- Voet D., 1995, Biochemistry, 315
- StancuC. NiculescuL. ToporanD. SimaA. IoanA. SimionescuM. Statins produce antiatherosclerotic effects in coronary heart disease patients Proceedings of the Romanian Academy 2001(in press).
Cited by
Sorted by citations
Items 801–900 of 910
Applications of Nanomaterials on Atherosclerosis
Shen, X. (2020) · International Conference on Artificial Intelligence and Electromechanical Automation (AIEA) · doi:10.1109/aiea51086.2020.00164
In-vitro Examination of The Potential Antibacterial Activity of Simvastatin
Almukhtar, H. M., Altaii, H. A., & Khalaf, M. M. (2020) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2020.0167599
Statins: Preventive Measure for Cardiovascular Disease in Elderly Population
Mohamed, A., Benoy, A. M., Xavier, A. M., & Jacob, R. (2021) · American Journal of PharmTech Research · doi:10.46624/ajptr.2021.v11.i1.003
Mendes, A. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2020.tde-08042021-081746
The Increase of Maxillary Lateral Expansion Limit by Local Application of Fluvastatin
Ishii, T., Sueishi, K., & Nishii, Y. (2021) · International Journal of Oral-Medical Sciences · doi:10.5466/ijoms.20.37
Ravali, R. S., Lakshmi, K. S., Vijayakumar, T. M., & Kumar, J. S. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100359
Mechanisms of Blood Brain Barrier Dysfunction in Stroke: A Therapeutic Opportunity
Sami, A. (2021) · UA Campus Repository (The University of Arizona)
Type 1 Interferon Limits Phagocyte Antimicrobial Function by Modulating Lysosomal Cholesterol
Tan, J. M. J. (2019) · TSpace (University of Toronto)
Matsuzaki, S., Miller, H., Takiuchi, T., Klar, M., & Matsuo, K. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1973427 · Cited by 1
Inflammatory profiles in acute coronary syndromes
Kristono, G. A. (2021) · Otago University Research Archive (University of Otago)
The Effects of Statins on Cardiac Function and Oxidative Status in Rats with Sepsis
Šamanović, A. M., Muric, M. D., Zivkovic, V. I., Mijailović, Ž., Jevtić, A., Andjic, M. M., Draginic, N. D., Savić, M., Bolevich, S., & Jakovljevic, V. L. (2021) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe52308.2021.9635204
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Madasamy, S., Liu, D., Lundry, J., Alderete, B. E., Kong, R., Robinson, J. P., Wu, A. H. B., & Amento, E. P. (2017) · Journal of Visualized Experiments · doi:10.3791/56596-v
Djohari, M., Mora, E., Emrizal, E., Angraini, C., & Aulia, F. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00013
Yulinery, T., Hardiningsih, R., & Nurhidayat, N. (2019) · Journal of Biota · doi:10.24002/biota.v15i1.2650
Comparative Effect of Atorvastatin and Rosuvastatin in cardiovascular Diseased patients
Kumar, S., Yashaswini, R., Gundlapally, P., & Althapu, S. (2022) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2022.06.0855
Sepehri, H., Nezhadebrahimi, A., Marjani, M., & Marjani, A. (2021) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2021.207190
Pharmacogenetics to Avoid Adverse Drug Reactions
López-Fernández, L. A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3343-8
Ödemiş, Z. B., Temiz, T. K., Balcı, E., Parlak, M., & Altun, A. (2012) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/1305-0028.1024
Lodola, A. (2011) · doi:10.1002/9780470909911.ch11
BELL, R. D., Lee, K., Pineda, C. C., & Brock, D. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50053-6
Ruilope, L. M., & Morales, E. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734368728.793555959
Statin Use in Children With Familial Hypercholesterolemia
(2020) · AAP Grand Rounds · doi:10.1542/gr.43-2-15
Haase, I., Fischer, M. J., Bacher, A., Eisenreich, W., & Rohdich, F. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb094
Saas, P., & Daguindau, É. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734959099.793559386
Shamsudin, A. F., & Bakar, N. S. (2022) · doi:10.22541/au.166721405.51189611/v1
In silico network-based screening reveals candidates for endothelial dysfunction therapyPreprint
Pinheiro‐de‐Sousa, I., Giudice, G., Fonseca‐Alaniz, M. H., Modestia, S. M., Viana-Mattioli, S., Fang, Y. H., Petsalaki, E., & Krieger, J. E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.17.516953
Salam, M. A., Rana, M. F., Baral, P. K., Rahman, M., Ahmed, S., Rahman, R., Jahan, N., Mazumder, T., Islam, M. S., & Hussain, M. S. (2023) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2023.7.17
Characterisation of B cells in Acute Coronary Syndromes
Bird, G. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.22098188
Camacho-Caballero, K. (2021) · Universidad Científica del Sur · doi:10.21142/tl.2021.1587
Statinler Doz Bağımlı Olarak Depo-Bağımlı Ca2+ Girişini Baskılar
Gökçe, Y. (2023) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1209500
Saka, M. H., & Faeq, A. K. (2018) · Advanced medical journal · doi:10.56056/amj.2018.67
Association between statin-use and mobility and long-term survival after major lower limb amputation
Wafi, A., Kolli, V., Ribeiro, L., Azhar, B., Budge, J., Chawla, S., Moxey, P. W., Loftus, I. M., & Holt, P. (2023) · Vascular · doi:10.1177/17085381231192724
The inhibitory effect of anthocyanins-rich Thai berries extracts on lipid digestion and absorption
Chamnansilpa, N. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.255
Karaaslan, Ö. Ç., Aksoy, A., Özilhan, M. O., Güray, Ü., Selçuk, M. T., Selçuk, H., & Maden, O. (2023) · Research in Cardiovascular Medicine · doi:10.4103/rcm.rcm_45_23
Djohari, M., Pratiwi, D., Sinata, N., & Rahmawati, N. (2023) · Jurnal Ilmiah Manuntung · doi:10.51352/jim.v9i2.679
To study the impact of biotin on dyslipidemia
Pundalikrao, S. A., & Uppala, H. (2020) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2020.v2.i1a.526
Nguyen, P., Singh, V., Thakur, V., Dwivedi, A. K., & Chattopadhyay, M. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241234962
Çocuk Sağlığı ve Hastalıkları ( AYBAK 2018 Eylül )
Kamaşak, T., Giritoğlu, N. I., Güven, B., Reis, G. P., Özdamar, M. Y., Deleş, B., Yapıcı, G., & Tunç, A. Y. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1476
Poncarová, M., Šorf, M., Poštulková, E., Klementová, Š., Hájek, J., Fojtíková, P., Kahoun, D., Hrouzek, P., Medková, D., & Petráňová, P. (2024) · Research Square · doi:10.21203/rs.3.rs-4012594/v1
RetractedAdditional file 1 of A phenome-wide association study of genetically mimicked statins
Li, S., & Schooling, C. M. (2021) · Figshare · doi:10.6084/m9.figshare.14880632
Kurniawati, A., Rahman, N., & Dwipajati, D. (2023) · Jurnal Penelitian Farmasi & Herbal · doi:10.36656/jpfh.v5i2.1121
Raja, K. D., Kumari, A. S., & Rani, A. P. (2024) · Toxicology International · doi:10.18311/ti/2024/v31i2/42123
Step 2 for the treatment of periodontal diseases: adjunctive therapies
Guo, K., & Sharma, P. (2024) · Dental Update · doi:10.12968/denu.2024.51.5.316
Aterosklerosiaren fisiopatologia: disfuntzio endotelialetik plakaren hausturara
Jebari‐Benslaiman, S., Larrea, A., Uribe, K. B., Benito‐Vicente, A., García, U. G., Urteaga, A. S. J., & Martı́n, C. (2024) · Osagaiz osasun-zientzien aldizkaria · doi:10.26876/osagaiz.1.2024.575
Reducing CETP activity prevents memory decline in an Alzheimer’s disease mouse model
Phénix, J., Sarty, I. M., Katz, M. S., Cobá, A. V., Marure-Rojano, A. E., Nie, H., Kerksiek, A., Jerry, I., Berger, C. S., Kiss, R. S., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00482-w · Cited by 3
Heart, lungs, and statins: is it an easy cohabitation? Pitfalls and controversies
Polito, D., Segreti, A., Piscione, M., Vespasiano, F., Nafisio, V., Cavallari, I., Ussia, G. P., Incalzi, R. A., & Grigioni, F. (2024) · Minerva Respiratory Medicine · doi:10.23736/s2784-8477.24.02137-5
Rotstein, I. (2025) · Journal of Dental Health and Oral Research · doi:10.46889/jdhor.2025.6105
AbuDujain, N. M., Aljofan, Z., Alhumimidi, A. S., Batais, M. A., Almutairi, Y., Alsayed, S., Alsadhan, K. F., Alrasheed, A. A., & Almigbal, T. H. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003244
Unclogging the heart: the potential of statins to reverse coronary artery blockage
Oza, Y. R., Pathak, K., Rana, R., Mehta, D., & Patel, K. K. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20251346
Al‐Jarallah, M., Rajan, R., Dashti, R., Bulbanat, B., Ridha, M., Sulaiman, K., Al-Zakwani, I. S., Alsheikh-Ali, A. A. A., Panduranga, P., AlHabib, K. F., et al. (2025) · Current Vascular Pharmacology · doi:10.2174/0115701611311671250416054455 · Cited by 1
Mao, S., Ma, Z., Zhang, G., Ma, P., Li, C., & Ye, L. (2025) · Journal of Dental Sciences · doi:10.1016/j.jds.2025.04.024
Wu, T., Zhang, L., Tian, J., Lu, Y., Yang, Y. F., Yang, X., Jin, P., Gu, Y., Wang, X., & Lin, Y. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02625-3
Ali, S., Ali, U., & Jan, M. I. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2519976
Goel, E., Mkhreb, S. S., Cotti, E., Ideo, F., Niazi, S. A., Koller, G., Farzadi, S., & Mannocci, F. (2025) · Journal of Endodontics · doi:10.1016/j.joen.2025.06.010
Hanley, B. (2025) · Springer eBooks · doi:10.1007/978-3-032-00292-1_4
Yezerski, A., Ni, J., Schwartz, A., Peters, L., Pavlico, M., & Kizer, A. (2025) · Academia Environmental Sciences and Sustainability · doi:10.20935/acadenvsci7895
Suta, S., Pinsawas, B., Surawit, A., Ophakas, S., Wang, Y., Du, Y. Y., Shen, X., Pasookhush, P., Mongkolsucharitkul, P., Soonkum, T., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7577991/v1
Doku, R., Osafo, N. Y., Kwagyan, J., & Southerland, W. M. (2025) · medRxiv · doi:10.1101/2025.10.23.25338682
Peng, Y., Li, X., Gao, Z., Wang, R., Wu, X., Sun, Y., Li, X., & Yang, X. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04658-3
Feldt, M., Menard, J. A., Rosendahl, A. H., Lettiero, B., Bendahl, P.-O., Belting, M., & Borgquist, S. (2020) · Figshare · doi:10.6084/m9.figshare.13279076
Engell, A. E., Jørgensen, H. L., Lind, B., Pottegård, A., Andersen, C. L., Andersen, J. S., Kriegbaum, M., Grand, M. K., & Bathum, L. (2021) · Figshare · doi:10.6084/m9.figshare.16909963
Shamsudin, A. F., Sulong, S., Ahmad, I., & Bakar, N. S. (2024) · Figshare · doi:10.6084/m9.figshare.25621852
Engell, A. E., Jørgensen, H. L., Lind, B., Pottegård, A., Andersen, C. L., Andersen, J. S., Kriegbaum, M., Grand, M. K., & Bathum, L. (2021) · Figshare · doi:10.6084/m9.figshare.16909966
Feldt, M., Menard, J. A., Rosendahl, A. H., Lettiero, B., Bendahl, P.-O., Belting, M., & Borgquist, S. (2020) · Figshare · doi:10.6084/m9.figshare.13279082
Feldt, M., Menard, J. A., Rosendahl, A. H., Lettiero, B., Bendahl, P.-O., Belting, M., & Borgquist, S. (2020) · Figshare · doi:10.6084/m9.figshare.13279073
Ideo, F., Manca, M. F., Niazi, S. A., Mannocci, F., Bardini, G., & Cotti, E. (2024) · Figshare · doi:10.6084/m9.figshare.26624461
Ideo, F., Manca, M. F., Niazi, S. A., Mannocci, F., Bardini, G., & Cotti, E. (2024) · Figshare · doi:10.6084/m9.figshare.26624464
Engell, A. E., Jørgensen, H. L., Lind, B., Pottegård, A., Andersen, C. L., Andersen, J. S., Kriegbaum, M., Grand, M. K., & Bathum, L. (2021) · Figshare · doi:10.6084/m9.figshare.16909969
Ideo, F., Manca, M. F., Niazi, S. A., Mannocci, F., Bardini, G., & Cotti, E. (2024) · Figshare · doi:10.6084/m9.figshare.26624467
Liu, Y., Liu, P., Song, Y., Li, S., Shi, Y., Quan, K., Yu, G., Li, P., An, Q., & Zhu, W. (2021) · Figshare · doi:10.6084/m9.figshare.14516311
Additional file 2 of A phenome-wide association study of genetically mimicked statins
Li, S., & Schooling, C. M. (2021) · Figshare · doi:10.6084/m9.figshare.14880635
Feldt, M., Menard, J. A., Rosendahl, A. H., Lettiero, B., Bendahl, P.-O., Belting, M., & Borgquist, S. (2020) · Figshare · doi:10.6084/m9.figshare.13279079
Role of Disease-Modifying Immunosuppressive Drugs in Thyroid Eye Disease
Davidoss, N., & Ford, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-99672-6_18
Computational Modeling and Quality Validation of HMG-CoA Reductase for Drug Design Applications
Rubaya, Rahman, M. M., & Mahmud*, S. (2025) · American Journal of Pure and Applied Biosciences · doi:10.34104/ajpab.025.04850498
IL27RA is a promising key target for statins in treating hyperlipidemia
Zhao, N., Li, Y. M., & Liu, Y. (2026) · 3 Biotech · doi:10.1007/s13205-025-04668-w
Berube, A. J., Yu, E., Gaheer, P. S., & Lanktree, M. B. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106350
Mostafa, A. A., El‐Hay, S. S. A., Metias, Y. M., Said, M. A., & Fawzy, M. G. (2026) · RSC Advances · doi:10.1039/d5ra09502f
Godini, E., & Siavoshi, F. (2026) · International Microbiology · doi:10.1007/s10123-026-00784-6
Statin Therapy Alters the Distribution of the LDL-C/HDL-C Ratio: A Weibull Modeling StudyPreprint
Nakayama, N., Imai, K., Niwa, S., Moriwaki, Y., Furukawa, N., & Hirai, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9044847/v1
Maideen, N. M. P., Jumale, A. H., Albasti, A. K., Kadir, D. A. A., Alkhawalda, M. Y., Shokr, A. F., & Canani, M. (2026) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x429107251202110301
Xu, J., Qin, X., Xiong, L., Zhao, C., Ge, D., Wu, Y., Shen, Y., Yang, M., Shen, B., Chen, M., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02802-6
Hardy, L. M. (2019) · theses.fr (ABES) · doi:10.70675/2f5f4b0dzc92fz4cb4z9c5bzeb6d3fd3e791
Habib, M. (2022) · theses.fr (ABES) · doi:10.70675/e634ffe7zc86dz4e0fzb03dz223ee5589a93
de Fondaumière, M. (2023) · theses.fr (ABES) · doi:10.70675/9dc73a0az2db9z4547zb5b3z6d65b7b632bc
Mvongo, C., Mfopa, A., Mukam, J. N., Noubissi, P. A., TCHOUNDJWEN, S. N., DINGAN, S. W. K., Tchizé, A. G. N., Tagne, M. A. F., Kamgang, R., & Oyono, J.-L. E. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.145029
SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity
Pala, B., Piscione, M., Marcantonio, M. C. D., Cribari, F., Vitale, R., Baldi, T., Popolo, A., & Mincione, G. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1846253
Association Between Statin Use and Dry Eye Disease: A Systematic Review and Meta-Analysis
Gou, D., Qiu, W., Chang, V., Weiler, L., Mihalache, A., Balas, M., Ahmed, Y., Alsarhani, W. K., Tao, B. K.-L., Teichman, J. C., et al. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2026.06.031
Chan, L. S., Xu, W., Chan, E. W., & Wan, E. Y. F. (2026) · PLoS Medicine · doi:10.1371/journal.pmed.1005136
Carda‐Broch, S., Péris-Vicente, J., Bose, D., Durgbanshi, A., & Ruiz-Ángel, M. J. (2026) · Microchemical Journal · doi:10.1016/j.microc.2026.118886
Dixit, C., Paliwal, D., Mondal, R., Thakur, A., & Rahaman, S. A. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814328126010005
The impact of phytochemicals on statin efficacy and safety: A review
Vatankhah, P., Alamdari-Palangi, V., Kian, M., Hosseinpour-Soleimani, F., Savardshtaki, A., Tajbakhsh, A., & Hashempur, M. H. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179129
Elsaeed, N. K., Abdelmoety, R. H., Elyamani, E., Mahmoud, L. M., Zidan, M., Matter, L. M., Imam, M. S., Alosaimi, F. M., Alosaimi, F., Almehery, A. A., et al. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-01013-7
Metadata
- Authors
- Stancu, C., & Sima, A.
- Affiliations
- Romanian Academy (RO)
- Corresponding author
- Sima, Anca
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 5
- Issue
- 4
- Pages
- 378-387
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- PMC
- PMC6740083
- OpenAlex
- W2006572302
- Cited by
- 911
- References
- 42
- Citations by year
- 2026: 35 · 2025: 65 · 2024: 73 · 2023: 81 · 2022: 90 · 2021: 94 · 2020: 96 · 2019: 66 · 2018: 51 · 2017: 48 · 2016: 35 · 2015: 25 · 2014: 34 · 2013: 22 · 2012: 18
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Cellular and Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- statins, HMG-CoA reductase inhibition, cholesterol biosynthesis, lipid metabolism, LDL cholesterol, atherosclerosis, mevalonate metabolism, terpenoids, pleiotropy, coronary events, bone formation, tumor cell proliferation, primary and secondary prevention
- MeSH terms
- Cholesterol Esters, Endothelium, Vascular, Humans, Hypercholesterolemia, Liver, Models, Biological, Muscle, Smooth, Vascular, Molecular Structure, Signal Transduction, Platelet Activation, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review